| abstract |
The present application relates to an injectable pharmaceutical formulation comprising nanofibrillar cellulose hydrogel wherein the content of nanofibrillar cellulose in the pharmaceutical formulation is the range of 1-8% (w/w), and pharmaceutical compound. The present application also relates to the injectable pharmaceutical formulation for use for providing a sustained release of a pharmaceutical compound in a subject, and to use of nanofibrillar cellulose for preparing the injectable pharmaceutical formulation. |